ARTICLE | Company News
IntegraGen, Pfizer deal
April 14, 2014 7:00 AM UTC
IntegraGen said it granted Pfizer access to evaluate IntegraGen's 56-gene molecular signature to predict clinical prognosis of hepatocellular carcinoma patients. The signature is also intended to help...